Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02151058 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain Removal

A NA study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.

Completed
Registry status
NA
Development phase
227
Enrollment target

NCT02151058: Completed NA study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.

NCT02151058 is a NA study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 227 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02151058, a NA study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.

COMPLETED
Registry status
NA
Development phase
227 participants
Enrollment target

Study Summary

The whitening action of an investigative hydrogen peroxide/sodium fluoride containing mouth rinse will be evaluated through stain removal using mean Lobene Stain Index over 14 days compared to a currently marketed hydrogen peroxide containing whitening mouth rinse (Crest® 3D White Multi-Care Whitening Rinse, Glamorous White, Fresh Mint). A currently marketed toothpaste (Colgate® Cavity Protection) will be included as the negative control in order to compare to brushing alone. 225 healthy volunteers will be enrolled in this two week study. Volunteers who qualify to be in this study will have an equal chance of being assigned to one of the three treatment groups. Volunteers will have a total of 5 clinic visits including 1) screening, 2) baseline 3) Day 4 (after 3 days of use), Day 8 (after 7 days of use) and Day 15 (after 14 days of use). Volunteers will maintain a diary at home to record each treatment use. Examinations for oral hard/soft tissue assessment and extrinsic tooth stain after the subject brushes with water and floss will be completed at Baseline and repeated at Clinic Visits 3, 4, and 5, which are on Days 4, 8 and 15 post baseline (i.e., after 3, 7, and 14 days of product use).

Primary Outcome

Tooth stain surface and stain intensity were assessed by using scores on the Lobene Stain Index (two part visual scale), scored 0 - 3. Where 0 = no stain, 1 = light stain, 2 = moderate stain and 3 = heavy stain. The second part of the scale examined the surface of the tooth on a scale of 0-3, where 0= no stain, 1 = covering up to 1/3 of the region, 2 = covering \> 1/3 to 2/3 of the region and 3 = covering \> 2/3 of the region. The mean composite score (0-9) was determined by multiplying the ind

Interventions

  • DRUG Colgate® Regular Cavity Protection
  • DRUG Experimental Mouth Rinse
  • OTHER Crest® 3D White Multi-Care Whitening Rinse, Glamorous White, Fresh Mint

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2014-06
Est. Completion 2014-07
Phase NA

What the finished NCT02151058 record still lists

NCT02151058 is an interventional study that assigns participants to a tested intervention. The registered 227 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 3 interventions - of which Colgate® Regular Cavity Protection is the first listed.

NCT02151058 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02151058 about?

NCT02151058 is a clinical study titled "A Clinical Trial to Test the Effect of a Marketed Mouth Rinse on Stain Removal". The whitening action of an investigative hydrogen peroxide/sodium fluoride containing mouth rinse will be evaluated through stain removal using mean Lobene Stain Index over 14 days compared to a currently marketed hydrogen peroxide containing whitening mouth rinse (Crest® 3D White Multi-Care Whiteni...

What is the current status of trial NCT02151058?

This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2014-06. Estimated completion is 2014-07.

What interventions are being tested in trial NCT02151058?

The interventions under investigation include: Colgate® Regular Cavity Protection (DRUG), Experimental Mouth Rinse (DRUG), Crest® 3D White Multi-Care Whitening Rinse, Glamorous White, Fresh Mint (OTHER).

Who is sponsoring clinical trial NCT02151058?

This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02151058's enrollment target sits among peer trials

227 471st of 2000 higher than 1,530 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04751409 · 227 participants · Phase 2

    Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

  • NCT05742360 · 227 participants

    Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

  • NCT05890352 · 227 participants · Phase 2

    Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02151058, the US trial registry maintained by the National Library of Medicine. NCT02151058 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.